Tipsheet
What matters at India’s listed companies
Chemicals · Small cap

Foseco India gets ₹11.99 cr for subsidiary stake, vs ₹134.75 cr estimate

Actual proceeds from selling 1.77% of Foseco Crucible were 91% below the May estimate, but the deal is only 0.3% of market cap.


Mkt cap₹3,913 cr
P/E54.13×
ROE6.98%
Debt / eq.0.00
Div yld0.47%
₹11.99 cr Actual consideration for 1.77% subsidiary stake — 91% below earlier estimate

What's new

  • Sold 1.77% of subsidiary Foseco Crucible for ₹11.99 cr to meet public float.
  • Proceeds were 91% below the ₹134.75 cr estimate announced in May.
  • Shareholding in subsidiary reduced to 75%.

Why this matters

The staggering gap between estimated and actual consideration raises questions about the original disclosure. However, the ₹11.99 cr is just 0.3% of Foseco India's ₹3,973 cr market cap, making it financially immaterial. The sale itself is routine compliance.

What we're watching

  • Whether the company explains the 91% estimate error.
  • Any further stake sales if public float needs adjustment.
  • SEBI's stance on such large forecast revisions.

The full read

Foseco India sold 1.77% of its subsidiary Foseco Crucible through open market trades for ₹11.99 crore — a far cry from the ₹134.75 crore it estimated in May. The 91% shortfall is jarring, yet the transaction is too small to matter for Foseco: just 0.3% of its ₹3,973 crore market cap. The sale was purely compliance-driven, bringing the subsidiary to the mandatory 75% holding threshold. What stands out is the disclosure gap, not the numbers themselves.

Questions answered

How much stake did Foseco India sell in its subsidiary?
It sold 99,081 shares, representing 1.77% of Foseco Crucible's paid-up capital, reducing its holding to 75%.
Why was the sale price 91% lower than the earlier estimate?
The company had estimated ₹134.75 cr on May 12, 2026, but the actual open market proceeds were only ₹11.99 cr. The filing does not explain the drastic revision.
Is this sale financially material for Foseco India?
No. The ₹11.99 cr is about 0.3% of its ₹3,973 crore market cap, well below materiality thresholds for a small-cap company.
Why did Foseco India sell this stake?
To comply with SEBI's minimum public shareholding norms for its subsidiary, Foseco Crucible.
Will Foseco India need to sell more shares in the subsidiary?
Now that its holding is exactly 75%, the subsidiary meets the public float requirement. No further sales are needed unless regulations change.
Mentioned: Foseco Crucible (India) Limited · ₹134.75 crore estimate · ₹11.99 crore actual · SEBI
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

Company snapshot

Foseco India Ltd.

Chemicals
₹3,999 cr
P/E 55.32×

Latest quarter · Mar 2026

Sales₹202 cr
Net profit₹33 cr
Op. margin+20.5%
EPS₹44.86

Strength & growth

Debt / equity0.00×
Current ratio2.90×
Sales CAGR+8.2%
EPS CAGR+6.1%